701 related articles for article (PubMed ID: 16257344)
1. Advances in leishmaniasis.
Murray HW; Berman JD; Davies CR; Saravia NG
Lancet; 2005 Oct 29-Nov 4; 366(9496):1561-77. PubMed ID: 16257344
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Treatment of Leishmaniasis.
Sundar S; Chakravarty J
Pediatr Infect Dis J; 2024 Jun; ():. PubMed ID: 38907629
[No Abstract] [Full Text] [Related]
3. Leishmaniasis worldwide and global estimates of its incidence.
Alvar J; Vélez ID; Bern C; Herrero M; Desjeux P; Cano J; Jannin J; den Boer M;
PLoS One; 2012; 7(5):e35671. PubMed ID: 22693548
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous leishmaniasis.
Reithinger R; Dujardin JC; Louzir H; Pirmez C; Alexander B; Brooker S
Lancet Infect Dis; 2007 Sep; 7(9):581-96. PubMed ID: 17714672
[TBL] [Abstract][Full Text] [Related]
5. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis F; Sundar S; Hailu A; Ghalib H; Rijal S; Peeling RW; Alvar J; Boelaert M
Nat Rev Microbiol; 2007 Nov; 5(11):873-82. PubMed ID: 17938629
[TBL] [Abstract][Full Text] [Related]
6. Leishmaniasis: complexity at the host-pathogen interface.
Kaye P; Scott P
Nat Rev Microbiol; 2011 Jul; 9(8):604-15. PubMed ID: 21747391
[TBL] [Abstract][Full Text] [Related]
7. Leishmaniasis.
Pace D
J Infect; 2014 Nov; 69 Suppl 1():S10-8. PubMed ID: 25238669
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniasis: clinical syndromes and treatment.
McGwire BS; Satoskar AR
QJM; 2014 Jan; 107(1):7-14. PubMed ID: 23744570
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous and mucocutaneous leishmaniasis.
David CV; Craft N
Dermatol Ther; 2009; 22(6):491-502. PubMed ID: 19889134
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in leishmaniasis.
Croft SL; Sundar S; Fairlamb AH
Clin Microbiol Rev; 2006 Jan; 19(1):111-26. PubMed ID: 16418526
[TBL] [Abstract][Full Text] [Related]
11. New World and Old World Leishmania Infections: A Practical Review.
Kevric I; Cappel MA; Keeling JH
Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
[TBL] [Abstract][Full Text] [Related]
12. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
Goto H; Lindoso JA
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):419-33. PubMed ID: 20377337
[TBL] [Abstract][Full Text] [Related]
13. Leishmaniasis and poverty.
Alvar J; Yactayo S; Bern C
Trends Parasitol; 2006 Dec; 22(12):552-7. PubMed ID: 17023215
[TBL] [Abstract][Full Text] [Related]
14. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.
Berman JD
Clin Infect Dis; 1997 Apr; 24(4):684-703. PubMed ID: 9145744
[TBL] [Abstract][Full Text] [Related]
15. Injectable paromomycin for Visceral leishmaniasis in India.
Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
[TBL] [Abstract][Full Text] [Related]
16. Leishmaniasis: current status of available drugs and new potential drug targets.
Singh N; Kumar M; Singh RK
Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
[TBL] [Abstract][Full Text] [Related]
17. Leishmaniasis chemotherapy--challenges and opportunities.
Croft SL; Olliaro P
Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leishmaniasis: recent developments in diagnosis and management.
de Vries HJ; Reedijk SH; Schallig HD
Am J Clin Dermatol; 2015 Apr; 16(2):99-109. PubMed ID: 25687688
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Cutaneous Leishmaniasis Caused by Leishmania aethiopica: A Systematic Review.
van Griensven J; Gadisa E; Aseffa A; Hailu A; Beshah AM; Diro E
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004495. PubMed ID: 26938448
[TBL] [Abstract][Full Text] [Related]
20. Leishmaniasis: an update of current pharmacotherapy.
Sundar S; Chakravarty J
Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
